Projects funded by the NCN

Oxidation products of 5-methylcytosine as a new predictive markers for respons to systemic chemotherapy of breast cancer...

Call: OPUS 9 , Panel: NZ5

Principal investigator: dr hab. Marek Foksiński

Uniwersytet Mikołaja Kopernika, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy

5-Hydroxymethylcytosine (sixth DNA base) and its putative derivative - 5-hydroxymethyluracil as a new cancer biomarkers?...

Call: OPUS 5 , Panel: NZ5

Principal investigator: prof. Ryszard Oliński

Uniwersytet Mikołaja Kopernika, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Wydział Farmaceutyczny

A search for a link between epigenetical changes - active DNA demethylation and oxidative stress based on cell culture s...

Call: OPUS 4 , Panel: NZ1

Principal investigator: prof. Ryszard Oliński

Uniwersytet Mikołaja Kopernika, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Wydział Farmaceutyczny

Uracil in DNA and aberrant DNA methylation/hydroxymethylation as a new biomarkers of multiple myeloma development? A sea...

Call: OPUS 20 , Panel: NZ5

Principal investigator: prof. Ryszard Oliński

Uniwersytet Mikołaja Kopernika w Toruniu, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Wydział Farmaceutyczny

The impact of selective estrogen receptor modulators (SERMs) on active DNA demethylation in breast cancer cell lines

Call: PRELUDIUM 15 , Panel: NZ3

Principal investigator: Kinga Linowiecka

Uniwersytet Mikołaja Kopernika, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy

Investigation of involvement of particular TET protein family members in the generation of epigenetic DNA modyfications.

Call: PRELUDIUM 15 , Panel: NZ1

Principal investigator: Maciej Gawroński

Uniwersytet Mikołaja Kopernika w Toruniu, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Wydział Farmaceutyczny

A search for mechanism of anticancer properities of vitamin C; possible link between epigenetic DNA modyfications and vi...

Call: OPUS 14 , Panel: NZ7

Principal investigator: prof. Ryszard Oliński

Uniwersytet Mikołaja Kopernika, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Wydział Farmaceutyczny

2-ketoglutarate and 2-hydroxyglutarate as a potential metabolic modulators of an active DNA demethylation process among ...

Call: PRELUDIUM 13 , Panel: NZ5

Principal investigator: dr Martyna Modrzejewska

Uniwersytet Mikołaja Kopernika, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Wydział Farmaceutyczny

Products of DNA demethylation and deamination pathways as new biomarkers of development and predictors of the outcome in...

Call: OPUS 10 , Panel: NZ5

Principal investigator: dr hab. Daniel Gackowski

Uniwersytet Mikołaja Kopernika, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Wydział Farmaceutyczny